| Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 |
---|---|---|---|---|---|---|---|
Gender | Male | Male | Female | Male | Female | Female | Male |
Ethnicity | - | Causasian | Caucasian | Caucasian | Caucasian | Caucasian | Asian |
Onset | 34 months | 1st grade | 18–19 years | Childhood | 23 years | Childhood | 25 years |
Chief complaint | Difficulty rising | Difficulty running | Exertional myalgias | Difficulty running | Difficulty with stairs | Difficulty running | Difficulty with stairs |
Calf pseudohypertrophy | Present | - | None | Present | None | Present | Medial calf atrophy |
Heel cords | Contracted | - | Normal | Unknown | Contracted | Normal | - |
Facial strength | Normal | Mild weakness | Normal | Normal | Normal | Normal | Normal |
Scapular winging | - | - | - | - | Subtle | Subtle | Subtle |
Proximal upper extremity strength | - | 4+ | 4- | 5 | 4- | 4 | 4+ |
Distal upper extremity strength | - | 5 | 5 | 5 | 4+ to 5 | 4+ | 5 |
Proximal lower extremity strength | Weak | 2+ to 3+ | 3- to 4- | 2 to 3 | 2 | 3- to 3 | 3- to 4- |
Distal lower extremity strength | - | 5 | 5 | 5 | 4 | 4 | 5- to 5 |
Reflexes | 2+ | Trace | 2+ | 1+ to 2+ | 1+ to 2+ | 2+ | 2+ |
FVC (% predicted) | - | - | - | - | 2.72L (83%) | 2.87L (75%) | 3.03L (56%) |
Echocardiogram (ejection fraction) | Normal | - | Normal (55%) | Angiogram normal | Normal (>55%) | ~45% | (>55%) |
Creatine kinase (U/L) | 5,438 | 5,000+ | 1,945 | 3–4 times normal | 1,136 | 5,031 | 6,560 to 10,642 |
Dystrophin duplication/deletion | None | - | None | None | - | - | - |
Age at biopsy | 3 1/2 years | 17 years | 30 years | 51 years | 27 years | 25 years | - |
Muscle sampled | Left quadriceps | Left biceps | Deltoid | Left quadriceps | Biceps | Deltoid | - |
Dystrophin staining | Normal | Normal | Normal | Normal | Normal | Normal | - |
Merosin staining | Normal | - | - | - | - | Decreased | - |
Sarcoglycans (α,β,γ,δ) | Normal | Normal | Normal | - | Normal | Normal | - |
β-dystroglycan | Normal | - | Normal | - | Normal | Normal | - |
Spectrin | - | Normal | Normal | - | Normal | Normal | - |
FKRP mutation | c.826C>A, p.L276I (homozygous) | c.826C>A, p.L276I (homozygous) | c.826C>A, p.L276I (homozygous) | c.826C>A, p.L276I (homozygous) | c.826C>A, p.L276I (homozygous) | c.826C>A, p.L276I (homozygous) | del 1006–1174 (169 basepair frameshift, heterozygous), c.328C>T, p.R110W (heterozygous) |